Association between plasma lysophosphatidic acid levels and bronchopulmonary dysplasia in extremely preterm infants: A prospective study

Association between plasma lysophosphatidic acid levels and bronchopulmonary dysplasia in extremely preterm infants: A prospective study

BackgroundLysophosphatidic acid (LPA) is implicated in bronchopulmonary dysplasia (BPD) pathogenesis, but clinical evidence is lacking. This study aimed to investigate LPA levels in preterm infants with and without BPD and explore LPA as a biomarker for predicting BPD occurrence.MethodsPremature inf...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric pulmonology 2023-12, Vol.58 (12), p.3516-3522
Hauptverfasser: Li, Huitao, Huang, Zilu, Yang, Chuanzhong, Han, Dongshan, Wang, Xuan, Qiu, Xiaomei, Zhang, Zhiwei, Chen, Xueyu
Format: Artikel
Sprache:eng
Schlagworte:
Lung diseases
Newborn babies
Plasma
Premature babies
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:BackgroundLysophosphatidic acid (LPA) is implicated in bronchopulmonary dysplasia (BPD) pathogenesis, but clinical evidence is lacking. This study aimed to investigate LPA levels in preterm infants with and without BPD and explore LPA as a biomarker for predicting BPD occurrence.MethodsPremature infants with a gestational age of
ISSN:8755-6863
1099-0496
1099-0496
DOI:10.1002/ppul.26685